Bactericidal effect of combinations of cephalosporins with tobramycin on clinical isolates of Escherichia coli, Klebsiella and Staphylococcus aureus.
J. H. T. Wagenvoort, L. Brus-Weijer, MARC F. MICHEL
Abstract
J. H. T. Wagenvoort, L. Brus-Weijer, MARC F. MICHEL
Abstract
The antimicrobial activities of the cephalosporins cefazolin, cefotaxime, moxalactam or ceftazidime in combination with tobramycin against clinical isolates of E. coli, of Klebsiella, of beta-lactamase-negative and beta-lactamase-producing S. aureus strains were compared in vitro by the checkerboard technique. Antibiotic dilutions differed by small arithmetic increments. Favourable interactions occurred with each bacterial species. This trend applied to third-generation cephalosporins against E. coli and Klebsiella as well as to cefazolin against S. aureus. The antibiotics with already the highest intrinsic activity generally exhibited also the most favourable interaction.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
The antimicrobial activities of the cephalosporins cefazolin, cefotaxime, moxalactam or ceftazidime in combination with tobramycin against clinical isolates of E. coli, of Klebsiella, of beta-lactamase-negative and beta-lactamase-producing S. aureus strains were compared in vitro by the checkerboard technique. Antibiotic dilutions differed by small arithmetic increments. Favourable interactions occurred with each bacterial species. This trend applied to third-generation cephalosporins against E. coli and Klebsiella as well as to cefazolin against S. aureus. The antibiotics with already the highest intrinsic activity generally exhibited also the most favourable interaction.
Key concepts: Cefazolin, Cefotaxime, Cephalosporin, Ceftazidime, Tobramycin, Microbiology, Moxalactam, Klebsiella